Cavitary lesions emerged rapidly in Pseudomonas aeruginosa pneumonia

Naoki Kawakami1, Shin Ohara2, Ho Namkoong3,4

  • 1Department of Emergency and Critical Care Medicine St. Luke's International Hospital Tokyo Japan.

Clinical Case Reports
|March 19, 2020
PubMed

Insights

Rapidly deteriorating patients with new lung cavities may have Pseudomonas aeruginosa pneumonia. Early consideration of this pathogen is crucial, especially in high-risk individuals, for timely diagnosis and treatment.

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Infectious Diseases

Background:

  • Community-acquired pneumonia (CAP) typically involves common pathogens.
  • Rapid clinical deterioration and cavitary lung lesions are unusual findings in CAP.
  • Pseudomonas aeruginosa is an opportunistic pathogen often associated with hospital-acquired infections.

Purpose of the Study:

  • To highlight the importance of considering Pseudomonas aeruginosa as a causative agent in specific pneumonia cases.
  • To correlate rapid clinical decline and radiological findings with P. aeruginosa infection.

Main Methods:

  • Retrospective analysis of patient cases with rapid deterioration and cavitary lung lesions.
  • Microbiological investigation for Pseudomonas aeruginosa.
  • Radiological assessment of lung lesions.

Main Results:

  • Pseudomonas aeruginosa was identified as the causative pathogen in patients with rapid deterioration.
  • Emergence of cavitary lung lesions was observed in these patients.
  • High-risk patients showed increased susceptibility.

Conclusions:

  • Pseudomonas aeruginosa should be strongly suspected in patients with rapid deterioration and emergent cavitary lung lesions, particularly those at high risk.
  • This pathogen must be considered even when initial presentation suggests community-acquired pneumonia.
  • Prompt identification and management of P. aeruginosa pneumonia can improve patient outcomes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
645
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
712
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
363